- Home
- HFBL vs SERA Comparison
HFBL vs SERA Comparison
Compare HFBL & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HFBL | SERA |
|---|---|---|
| Founded | 1924 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Precision Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 77.3M | 75.2M |
| IPO Year | 2010 | 2021 |
Fundamental Metrics
Financial Performance| Metric | HFBL | SERA |
|---|---|---|
| Price | $24.80 | $2.10 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 633.0 | ★ 21.7K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.83% | N/A |
| EPS Growth | 7.69 | ★ 32.32 |
| EPS | ★ 1.55 | N/A |
| Revenue | ★ $1,303,000.00 | $81,000.00 |
| Revenue This Year | N/A | $554.81 |
| Revenue Next Year | N/A | $517.27 |
| P/E Ratio | $16.13 | ★ N/A |
| Revenue Growth | ★ 17.49 | 5.19 |
| 52 Week Low | $13.70 | $1.56 |
| 52 Week High | $28.00 | $3.95 |
Technical Indicators
Market Signals| Indicator | HFBL | SERA |
|---|---|---|
| Relative Strength Index (RSI) | 52.27 | 48.52 |
| Support Level | $24.17 | $1.94 |
| Resistance Level | $28.00 | $2.21 |
| Average True Range (ATR) | 0.36 | 0.07 |
| MACD | -0.14 | 0.00 |
| Stochastic Oscillator | 38.78 | 33.25 |
Price Performance
Historical ComparisonAbout HFBL Home Federal Bancorp Inc. of Louisiana
Home Federal Bancorp Inc of louisiana operates as a bank holding company. It is a federally chartered stock savings bank, which provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial and multi-family segments. The company also invests securities held-to-maturity and securities available for sale.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.